Exosome Derived from Coronary Serum of Patients with Myocardial Infarction Promotes Angiogenesis Through the miRNA-143/IGF-IR Pathway
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exosome Derived from Coronary Serum of Patients with Myocardial Infarction Promotes Angiogenesis Through the miRNA-143/IGF-IR Pathway
Authors
Keywords
-
Journal
International Journal of Nanomedicine
Volume Volume 15, Issue -, Pages 2647-2658
Publisher
Informa UK Limited
Online
2020-04-21
DOI
10.2147/ijn.s242908
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial
- (2019) Daniel J F M Thuijs et al. LANCET
- Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data
- (2018) Stuart J Head et al. LANCET
- Exosome as a Novel Shuttle for Delivery of Therapeutics across Biological Barriers
- (2018) Chandan Kanta Das et al. MOLECULAR PHARMACEUTICS
- Cisplatin-resistant lung cancer cell–derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100–5p-dependent manner
- (2017) Xiaobing Qin et al. International Journal of Nanomedicine
- Metformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activities
- (2017) Claudio Pulito et al. Cell Discovery
- Exosomal transfer of miR-30a between cardiomyocytes regulates autophagy after hypoxia
- (2016) Yan Yang et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Role of Extracellular Vesicles and microRNAs on Dysfunctional Angiogenesis during Preeclamptic Pregnancies
- (2016) Carlos A. Escudero et al. Frontiers in Physiology
- Mesenchymal Stem Cell-Derived Exosomes Improve the Microenvironment of Infarcted Myocardium Contributing to Angiogenesis and Anti-Inflammation
- (2015) Xiaomei Teng et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Bovine milk exosomes contain microRNA and mRNA and are taken up by human macrophages
- (2015) Hirohisa Izumi et al. JOURNAL OF DAIRY SCIENCE
- The role of microRNAs in regulating myocardial ischemia reperfusion injury
- (2015) Zhi-Xing Fan et al. SAUDI MEDICAL JOURNAL
- Exosomes and exosomal miRNAs in cardiovascular protection and repair
- (2015) Costanza Emanueli et al. VASCULAR PHARMACOLOGY
- Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis
- (2014) Sonia A. Melo et al. CANCER CELL
- Exosomes
- (2014) Derek M. Yellon et al. CIRCULATION RESEARCH
- Biogenesis and secretion of exosomes
- (2014) Joanna Kowal et al. CURRENT OPINION IN CELL BIOLOGY
- Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the exosomal transfer of miR-320 into endothelial cells
- (2014) Xiaohong Wang et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- MicroRNA-143 inhibits tumor growth and angiogenesis and sensitizes chemosensitivity to oxaliplatin in colorectal cancers
- (2013) Xu Qian et al. CELL CYCLE
- Comparison of serum exosome isolation methods for microRNA profiling
- (2013) Kadri Rekker et al. CLINICAL BIOCHEMISTRY
- Anti-salusin-β antibody enhances angiogenesis after myocardial ischemia reperfusion injury
- (2013) Mayumi Masumura et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Local Inhibition of MicroRNA-24 Improves Reparative Angiogenesis and Left Ventricle Remodeling and Function in Mice With Myocardial Infarction
- (2013) Marco Meloni et al. MOLECULAR THERAPY
- Nitric oxide, a protective molecule in the cardiovascular system
- (2013) Jing Lei et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- Exosomes Mediate the Cytoprotective Action of Mesenchymal Stromal Cells on Hypoxia-Induced Pulmonary Hypertension
- (2012) Changjin Lee et al. CIRCULATION
- Mechanism of TNF-α autocrine effects in hypoxic cardiomyocytes: Initiated by hypoxia inducible factor 1α, presented by exosomes
- (2012) Xian Yu et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Hsp20 Functions as a Novel Cardiokine in Promoting Angiogenesis via Activation of VEGFR2
- (2012) Xiaowei Zhang et al. PLoS One
- A systematic approach to exosome-based translational nanomedicine
- (2012) Joshua L. Hood et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1
- (2012) Qing Xu et al. Journal of Molecular Cell Biology
- Exosomal miRNAs: Biological Properties and Therapeutic Potential
- (2012) Guoku Hu et al. Frontiers in Genetics
- Exosomes From Human CD34 + Stem Cells Mediate Their Proangiogenic Paracrine Activity
- (2011) Susmita Sahoo et al. CIRCULATION RESEARCH
- A Novel and Efficient Model of Coronary Artery Ligation and Myocardial Infarction in the Mouse
- (2010) Erhe Gao et al. CIRCULATION RESEARCH
- Emerging Roles for Natural MicroRNA Sponges
- (2010) Margaret S. Ebert et al. CURRENT BIOLOGY
- The role of microRNA in modulating myocardial ischemia-reperfusion injury
- (2010) Yumei Ye et al. PHYSIOLOGICAL GENOMICS
- MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice
- (2009) A. Bonauer et al. SCIENCE
- MicroRNAs
- (2008) Muller Fabbri et al. CANCER JOURNAL
- Inhibition of insulin-like growth factor-I receptor (IGF-IR) using NVP-AEW541, a small molecule kinase inhibitor, reduces orthotopic pancreatic cancer growth and angiogenesis
- (2008) Christian Moser et al. EUROPEAN JOURNAL OF CANCER
- MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
- (2008) Douglas D. Taylor et al. GYNECOLOGIC ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More